Enabling real-world, real-time monitoring of respiratory status, Strados Labs’ RESP™ Biosensor is the world’s first FDA-cleared wearable device that remotely and continuously captures lung sounds such as cough and wheeze. The RESP Biosensor offers an innovative, patient-centered approach to managing acute exacerbations of COPD (AE-COPD), capturing events of pulmonary change that allow for earlier interventions and reduced hospitalizations. Strados Labs uses its proprietary AI engine and library of pulmonary data points to automatically detect lung sound events, allowing for efficient review and reporting.
